Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen's First-of-its-Kind Skin Cancer Drug Wins U.S. Approval
Bloomberg
Tue, 10/27/15 - 09:25 pm
Tags:
Amgen, T-Vec, melanoma
Amgen, Cytokinetics heart failure drug succeeds in mid-stage study
Yahoo/Reuters
Tue, 10/27/15 - 09:56 am
Tags:
Amgen, Cytokinetics, Omecamtiv Mecarbil, chronic heart failure
Amgen Q3 Earnings: Here’s What To Expect
Bidness, ETC
Tue, 10/27/15 - 09:54 am
Tags:
Amgen, earnings
Amgen reviews privacy of patient assistance program for cholesterol drug
Pharmalot
Mon, 10/26/15 - 04:36 pm
Tags:
Amgen, Repatha, patient assistance programs
Amgen's T-Vec inches toward EU approval for melanoma
Fierce Biotech
Fri, 10/23/15 - 11:06 am
Tags:
Amgen, T-Vec, melanoma, Europe
PCSK9 drugmakers go Big Data to ID more eligible patients
Fierce Pharma Marketing
Wed, 10/21/15 - 11:34 am
Tags:
PCSK9 inhibitors, patients, Big Data, Amgen, Sanofi, Regeneron, Repatha, Praluent
Amgen's Innovation Counters Biosimilar Pressure
Morningstar
Mon, 10/19/15 - 10:03 am
Tags:
Amgen, innovation, biosimilars, Epogen, Aranesp, Neupogen
Did Amgen Waste $300 Million In Buying A Flawed Heart Drug?
Forbes
Mon, 10/12/15 - 01:39 pm
Tags:
Amgen, Eli Lilly, evacetrapib, CETP inhibitors, Dezima, TA-8995
Lilly Loses Its Bloom; Amgen, Regeneron Blossom
Barron's
Mon, 10/12/15 - 11:51 am
Tags:
Eli Lilly, Amgen, Regeneron, evacetrapib, Repatha
Amgen Was Clobbered in September -- Here's Why
Motley Fool
Fri, 10/9/15 - 10:08 am
Tags:
Amgen, Repatha, drug pricing
Amgen Turning the Tables on 'Generic' Competition
Motley Fool
Wed, 10/7/15 - 09:59 am
Tags:
Amgen, biosimilars, generics, patents, R&D
Express Scripts to Cover Both New Cholesterol Drugs
NASDAQ.com
Tue, 10/6/15 - 07:00 pm
Tags:
Express Scripts, Praluent, Repatha, PCSK9 inhibitors, Sanofi, Amgen, Regeneron
Analyst sees big things for Allergan, Amgen despite slow growth in China and biosimilar pressures
Fierce Pharma
Fri, 10/2/15 - 04:54 pm
Tags:
Allergan, Amgen
Novartis biosimilar copycat takes aim at Amgen's drug Enbrel
Yahoo/Reuters
Fri, 10/2/15 - 10:37 am
Tags:
Novartis, biosimilar, Amgen, Enbrel, rheumatoid arthritis, Sandoz
New cholesterol drugs won't be budget busters -Express Scripts
Yahoo/Reuters
Thu, 10/1/15 - 09:10 am
Tags:
Express Scripts, drug pricing, PCSK9 inhibitors, Repatha, Praluent, Amgen, Regeneron, Sanofi
How the Top Biotechs Handled the Valuation Shock
24/7 Wall St
Sat, 09/26/15 - 10:00 am
Tags:
biotech, Amgen, Biogene, Celgene, Gilead Sciences
5 Key Drugs That Just Won EU Endorsements
Investors.com
Sat, 09/26/15 - 09:29 am
Tags:
Europe, Gilead Sciences, Genvoya, Amgen, Kyprolis, Blincyto, Vertex Pharmaceuticals, Orkambi, Horizon Pharma, Ravicti
The Price War for New Cholesterol Drugs Is Heating Up
Motley Fool
Fri, 09/25/15 - 08:48 pm
Tags:
PCSK9 inhibitors, drug pricing, Regeneron, Sanofi, Amgen, Praluent, Repatha
Amgen's leukemia drug gets conditional European approval
Yahoo/Reuters
Fri, 09/25/15 - 09:51 am
Tags:
Amgen, Europe, Blincyto, acute lymphoblastic leukemia
Next-gen oncolytics upstart Replimune grabs a $30M transatlantic venture round
Fierce Biotech
Thu, 09/24/15 - 11:44 am
Tags:
Oncolytics, Replimune, T-Vec, Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.